Influence of inadequate antimicrobial therapy on prognosis in elderly patients with severe urinary tract infections

European Journal of Internal Medicine

Volumn 25, Issue 6, 2014, Pages 523-527

  Esparcia, Ana ^a   Artero, Arturo ^a   Eiros, José M ^b   Balaguer, Marta ^a   Madrazo, Manuel ^a   Alberola, Juan ^a   Nogueira, José M ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Elderly; Inadequate empirical antimicrobial therapy; Mortality; Urinary tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; APACHE; ARTICLE; BACTEREMIA; BLOOD CULTURE; COMMUNITY ACQUIRED INFECTION; COMORBIDITY; CROSS-SECTIONAL STUDY; DEMENTIA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PROGNOSIS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; URINALYSIS; URINARY TRACT INFECTION; DRUG THERAPY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STANDARDS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URINARY TRACT INFECTIONS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; APACHE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG THERAPY; FEMALE; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 84903382735     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.04.009     Document Type: Article

References (30)

1. L.E. Nicolle Urinary tract infections in the elderly Clin Geriatr Med 25 2009 423 436
2. M. Juthani-Mehta, V. Quagliarello, E. Perrelli, V. Towle, P.H. Van Ness, and M. Tinetti Clinical features to identify urinary tract infection in nursing home residents: a cohort study J Am Geriatr Soc 57 2009 963 970
3. S.W. Wright, K.D. Wrenn, M. Haynes, and D.W. Haas Prevalence and risk factors for multidrug resistant uropathogens in ED patients Am J Emerg Med 18 2000 143 146
4. G. Kahlmeter, P. Menday, and O. Cars Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection J Antimicrob Chemother 52 2003 1005 1010
5. P. Montravers, R. Gauzit, Muller, J.P. Marmuse, A. Fichelle, and J.M. Desmonts Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy Clin Infect Dis 23 1996 486 494
6. F. Álvarez-Lerma Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group Intensive Care Med 22 1996 387 394
7. S. Harbarth, J. Garbino, J. Pugin, J. Pugin, J.A. Romand, and D. Lew et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis Am J Med 115 2003 529 535
8. E.H. Ibrahim, G. Sherman, S. Wards, V.J. Fraser, and M.H. Kollef The influence of inadequate antimicrobial treatment of blood stream infections on patient outcomes in the ICU setting Chest 118 2000 146 155
9. M.L. Leone, A. Burgoin, S. Cambon, M. Dubuc, J. Albanese, and C. Martín Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome Crit Care Med 31 2003 462 467
10. S. Tal, V. Guller, S. Levi, R. Bardenestein, D. Berger, and I. Gurevich et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection J Infect 50 2005 296 305
11. B.S. Chin, M.S. Kim, S.H. Han, S.Y. Shin, H.K. Chol, and Y.T. Chae et al. Risk factors of all-cause in-hospital mortality among Korean elderly bacteremic urinary tract infection patients Arch Gerontol Geriatr 52 2011 50 55
12. S. Aguilar-Durán, J.P. Horcajada, L. Sorli, M. Montero, M. Salvadó, and J.P. Horcajada Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections J Infect 64 2012 478 483
13. P. Retamar, M.M. Portillo, M.D. López- Prieto, F. Rodríguez-López, M. de Cueto, and M.V. García et al. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis Antimicrob Agents Chemother 56 2012 472 478
14. N.D. Friedman, H.S. Kaye, J.E. Stout, S.A. McGarry, S.L. Trivette, and J.P. Briggs et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 137 2002 791 797
15. W. McCabe, and G.G. Jacson Gram negative bacteremia: II clinical, laboratory and therapeutic observations Arch Intern Med 110 1962 856 864
16. W.A. Knauss, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 828
17. R.C. Bone, R.A. Balk, F.B. Cerra, L.P. Dellinger, A.M. Fein, and W.A. Knaus et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1992 1644 1655
18. S.S. Lee, Y. Kim, and D.R. Chung Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis J Infect 62 2011 159 164
19. K. Thom, M.L. Schweizer, R.B. Osih, J.C. McGregor, J.P. Furuno, and E.N. Perencevich et al. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study BMC Infect Dis 8 2008 1 9
20. J. Marschall, D. Agniel, V.J. Fraser, J. Doherty, and D.K. Warren Gram negative bacteremia in non-ICU patients: factors associates with inadequate antibiotic therapy and impact on outcomes J Antimicrob Chemother 61 2008 1376 1383
21. K.K. Sacarsi, J.M. Feinglass, M.H. Scheetz, M.J. Postelnick, M.K. Bolon, and G.A. Noskin Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay Antimicrob Agents Chemother 50 2006 3355 3360
22. R. Zaragoza, A. Artero, J.J. Camarena, S. Sancho, R. González, and J.M. Nogueira The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit Clin Microbiol Infect 9 2003 412 418
23. A. Artero, R. Zaragoza, J.J. Camarena, S. Sancho, R. González, and J.M. Nogueira Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock J Crit Care 25 2010 276 281
24. J.R. Mc Donald, D. Friedman, J.E. Stout, D.J. Sexton, and K.S. Kaye Risk factors for ineffective therapy in patients with bloodstream infection Arch Intern Med 165 2005 308 313
25. J. Vallés, E. Calbo, E. Anoro, D. Fontanals, M. Xercavins, and E. Espelo et al. Bloodstream infections in adults: importance of healthcare-associated infections J Infect 56 2008 27 34
26. L. Genao, and G.T. Buhr Urinary tract infections in older adults residing in long-term care facilities Ann Longterm Care 20 2012 33 38
27. Y. Chen, O. Nitzan, W. Saliba, B. Chazan, R. Colodner, and R. Raz Are blood cultures necessary in the management of women with complicated pyelonephritis? J Infect 53 2006 235 240
28. C.H. Lee, S.Y. Chen, I.J. Chang, S.C. Chen, and S.C. Wu Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly and adult patients Medicine (Baltimore) 86 2007 138 144
29. A. Soriano, J.A. Martínez, and J. Mensa Septic shock should be included in multivariable models analysing the effect of empirical antibiotic therapy on mortality Clin Infect Dis 46 2008 1484 1485
30. M.H. Samore, K. Bateman, and S.C. Alder Clinical decision support and appropriateness of antimicrobial prescribing: a randomized trial JAMA 294 2005 2305 2314